Multiple signaling states of G-protein-coupled receptors

被引:182
作者
Perez, DM [1 ]
Karnik, SS [1 ]
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA
关键词
D O I
10.1124/pr.57.2.2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Studies have been amassed in the past several years indicating that an agonist can conform a receptor into an activation state that is dependent upon an intrinsic property of the agonist usually based upon its chemical composition. Theoretically, each different agonist could impart its own unique activation state. Evidence for multiple signaling states for the G-protein-coupled receptors will be reviewed and is derived from many different pharmacological behaviors: efficacy, kinetics, protean agonism, differential desensitization and internalization, inverse agonism, and fusion chimeras. A recent extension of the ternary complex model is suggested by evidence that the different processes that govern deactivation, such as desensitization and internalization, is also regulated by conformers specific to the agonist. Rhodopsin may serve as a primer for the study of multiple activation states. Therapeutic implications that utilize multiple signaling states hold vast promise in the rationale design of drugs.
引用
收藏
页码:147 / 161
页数:15
相关论文
共 99 条
[1]   Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: A site-directed spin-labeling study [J].
Altenbach, C ;
Yang, K ;
Farrens, DL ;
Farahbakhsh, ZT ;
Khorana, HG ;
Hubbell, WL .
BIOCHEMISTRY, 1996, 35 (38) :12470-12478
[2]   MOLECULAR-BIOLOGY OF THE VISUAL PIGMENTS [J].
APPLEBURY, ML ;
HARGRAVE, PA .
VISION RESEARCH, 1986, 26 (12) :1881-+
[3]  
ARDEN JR, 1995, J NEUROCHEM, V65, P1636
[4]   β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors [J].
Azzi, M ;
Charest, PG ;
Angers, S ;
Rousseau, G ;
Kohout, T ;
Bouvier, M ;
Piñeyro, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11406-11411
[5]   Agonist actions of "β-blockers" provide evidence for two agonist activation sites or conformations of the human β1-adrenoceptor [J].
Baker, JG ;
Hall, IP ;
Hill, SJ .
MOLECULAR PHARMACOLOGY, 2003, 63 (06) :1312-1321
[6]   Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus [J].
Barak, LS ;
Oakley, RH ;
Laporte, SA ;
Caron, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :93-98
[7]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[8]   CELLULAR SIGNALING BY AN AGONIST-ACTIVATED RECEPTOR G(S)ALPHA FUSION PROTEIN [J].
BERTIN, B ;
FREISSMUTH, M ;
JOCKERS, R ;
STROSBERG, AD ;
MARULLO, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8827-8831
[9]   Differential opioid agonist regulation of the mouse mu opioid receptor [J].
Blake, AD ;
Bot, G ;
Freeman, JC ;
Reisine, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :782-790
[10]   The 'magic tail' of G protein-coupled receptors: an anchorage for functional protein networks [J].
Bockaert, J ;
Marin, P ;
Dumuis, A ;
Fagni, L .
FEBS LETTERS, 2003, 546 (01) :65-72